Atlas Trials

Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL

Clinical trial NCT05465876 · WITHDRAWN

Trial details

NCT number
NCT05465876
Sponsor
Sunnybrook Health Sciences Centre
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaCOVID-19
Start date
2023-10-01
Primary completion
2024-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.